Serving India and South East Asia, Groupe Athena (GATA.PK) assists companies in obtaining FDA approval for pharmaceuticals, medical products and devices for export to America.
The company’s goal is to ensure that each client passes FDA inspection by assisting them from concept through development, with consultation through all the regulatory requirements, filings, and processes to achieve FDA compliance and approval.
With 12 consultants in offices in America and India, the expert consultants of Groupe Athena are in position to go to target companies in Asia and the regulatory authorities in the USA directly, consulting with our clients in the East to serve them completely in providing consultancy services for FDA compliance.
The FDA inspection process is complicated, especially for foreign drug and medical companies trying to export to the USA. Services include providing technical and regulatory consulting for biotechnical products, pharmaceuticals (over the counter, prescription and generics), diagnostics, medical equipment, and devices.
With all Indian founders, Groupe Athena also has a reputation for being the first choice for FDA regulatory consultancy in the region for their ability to understand the obstacles and complications for Indian and South East Asian companies, as well as the requirements that would be expected by the Food and Drug Administration in America.
Groupe Athena’s resources include a laboratory facility located in India to assist with testing and clinical trials for our clients.
Corporate Highlights:► GATA reported earnings of nearly $.05 per share in 2010.
► Since launch, GATA revenues are up over 400% in three years.
► A great business model, GATA helps companies secure FDA approval to
sell pharmaceuticals and med products in the United States.
► The Indian pharmaceutical industry is one of the fastest growing segments
of their economy with an average annual growth rate of 14% since 2002,
and worldwide sales of $5 billion.
For more information, visit groupeathena.com